Experience in the Use of Valdoxan in the Treatment of Post-Stroke Depression
Valdoxan at a dose of 25 mg per day for three months was used in 40 patients aged 55–85 years with post-stroke depression. Patients’ status was assessed clinically and in terms of a series of scales (Hamilton, MMSE, Tinnetti, etc.). High antidepressant efficacy and good tolerance were demonstrated. On the background of stabilization of the emotional background, patients showed improvements in motor and cognitive functions.